nDatalyze Past Earnings Performance
Past criteria checks 0/6
nDatalyze's earnings have been declining at an average annual rate of -42.8%, while the Healthcare Services industry saw earnings growing at 2.8% annually. Revenues have been declining at an average rate of 13.7% per year.
Key information
-42.8%
Earnings growth rate
-34.0%
EPS growth rate
Healthcare Services Industry Growth | -3.9% |
Revenue growth rate | -13.7% |
Return on equity | -58.4% |
Net Margin | -437.9% |
Last Earnings Update | 30 Nov 2023 |
Recent past performance updates
Revenue & Expenses BreakdownBeta
How nDatalyze makes and spends money. Based on latest reported earnings, on an LTM basis.
Earnings and Revenue History
Date | Revenue | Earnings | G+A Expenses | R&D Expenses |
---|---|---|---|---|
30 Nov 23 | 0 | -1 | 1 | 0 |
31 Aug 23 | 0 | -1 | 0 | 0 |
31 May 23 | 0 | -1 | 1 | 0 |
28 Feb 23 | 0 | -1 | 1 | 0 |
30 Nov 22 | 0 | -2 | 0 | 1 |
31 Aug 22 | 0 | -2 | 0 | 1 |
31 May 22 | 0 | -1 | 0 | 1 |
28 Feb 22 | 0 | -1 | 0 | 1 |
30 Nov 21 | 1 | -1 | 1 | 0 |
31 Aug 21 | 1 | -1 | 1 | 0 |
31 May 21 | 1 | -1 | 1 | 0 |
28 Feb 21 | 1 | -1 | 1 | 0 |
30 Nov 20 | 1 | 0 | 0 | 0 |
31 Aug 20 | 1 | 0 | 0 | 0 |
31 May 20 | 1 | 0 | 0 | 0 |
29 Feb 20 | 1 | 0 | 0 | 0 |
30 Nov 19 | 0 | 0 | 0 | 0 |
31 Aug 19 | 0 | 0 | 0 | 0 |
31 May 19 | 0 | 0 | 0 | 0 |
28 Feb 19 | 0 | 0 | 0 | 0 |
Quality Earnings: NDAT is currently unprofitable.
Growing Profit Margin: NDAT is currently unprofitable.
Free Cash Flow vs Earnings Analysis
Past Earnings Growth Analysis
Earnings Trend: NDAT is unprofitable, and losses have increased over the past 5 years at a rate of 42.8% per year.
Accelerating Growth: Unable to compare NDAT's earnings growth over the past year to its 5-year average as it is currently unprofitable
Earnings vs Industry: NDAT is unprofitable, making it difficult to compare its past year earnings growth to the Healthcare Services industry (15.4%).
Return on Equity
High ROE: NDAT has a negative Return on Equity (-58.4%), as it is currently unprofitable.